Advances in Decision Sciences

PDF
Advances in Decision Sciences / 2002 / Article

On this page

AbstractCopyright

Open Access

Volume 6 |Article ID 417529 | 20 pages | https://doi.org/10.1155/S1173912602000020

An integrated selection formulation for the best normal mean: the unequal and unknown variance case

Pinyuen Chen1 and Jun-Lue Zhang2

1Department of Mathematics, Syracuse University, USA

2Department of Mathematics, Indiana Univ. of Pennsylvania, USA

Abstract

This paper considers an integrated formulation in selecting the best normal mean in the case of unequal and unknown variances. The formulation separates the parameter space into two disjoint parts, the preference zone (PZ) and the indifference zone (IZ). In the PZ we insist on selecting the best for a correct selection (CS1) but in the IZ we define any selected subset to be correct (CS2) if it contains the best population. We find the least favorable configuration (LFC) and the worst configuration (WC) respectively in PZ and IZ. We derive formulas for P(CS1|LFC), P(CS2|WC) and the bounds for the expected sample size E(N). We also give tables for the procedure parameters to implement the proposed procedure. An example is given to illustrate how to apply the procedure and how to use the table.

Copyright © 2002 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

More related articles

61 Views | 314 Downloads | 1 Citation
PDF Download Citation Citation
Order printed copiesOrder

Related articles

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.